Publication Information

{'id': 'https://openalex.org/W2141289501', 'doi': 'https://doi.org/10.1124/dmd.111.038224', 'title': 'Application of Physiologically Based Pharmacokinetic Modeling to Understanding the Clinical Pharmacokinetics of UK-369,003', 'display_name': 'Application of Physiologically Based Pharmacokinetic Modeling to Understanding the Clinical Pharmacokinetics of UK-369,003', 'publication_year': 2011, 'publication_date': '2011-03-30', 'ids': {'openalex': 'https://openalex.org/W2141289501', 'doi': 'https://doi.org/10.1124/dmd.111.038224', 'mag': '2141289501', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21451120'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1124/dmd.111.038224', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S145039780', 'display_name': 'Drug Metabolism and Disposition', 'issn_l': '0090-9556', 'issn': ['0090-9556', '1521-009X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316283', 'host_organization_name': 'American Society for Pharmacology and Experimental Therapeutics', 'host_organization_lineage': ['https://openalex.org/P4310316283'], 'host_organization_lineage_names': ['American Society for Pharmacology and Experimental Therapeutics'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5013657469', 'display_name': 'Kenny J. Watson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I189718659', 'display_name': 'Pfizer (United Kingdom)', 'ror': 'https://ror.org/04x4v8p40', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I189718659']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Kenny J. Watson', 'raw_affiliation_strings': ['Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK.'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK.', 'institution_ids': ['https://openalex.org/I189718659']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002503854', 'display_name': 'John D. Davis', 'orcid': 'https://orcid.org/0000-0001-6282-1670'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'John Davis', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5016745322', 'display_name': 'Hannah M. Jones', 'orcid': 'https://orcid.org/0000-0003-2711-4545'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Hannah M. Jones', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.045, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 15, 'citation_normalized_percentile': {'value': 0.869597, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': '39', 'issue': '7', 'first_page': '1203', 'last_page': '1213'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11036', 'display_name': 'Antibiotics Pharmacokinetics and Efficacy', 'score': 0.9974, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10570', 'display_name': 'Drug Transport and Resistance Mechanisms', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.8895228}, {'id': 'https://openalex.org/C185867374', 'wikidata': 'https://www.wikidata.org/wiki/Q2562769', 'display_name': 'Physiologically based pharmacokinetic modelling', 'level': 3, 'score': 0.60954547}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5968038}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.36791587}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.2803121}], 'mesh': [{'descriptor_ui': 'D054706', 'descriptor_name': 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D010726', 'descriptor_name': 'Phosphodiesterase Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054706', 'descriptor_name': 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007262', 'descriptor_name': 'Infusions, Intravenous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010726', 'descriptor_name': 'Phosphodiesterase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010726', 'descriptor_name': 'Phosphodiesterase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010726', 'descriptor_name': 'Phosphodiesterase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1124/dmd.111.038224', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S145039780', 'display_name': 'Drug Metabolism and Disposition', 'issn_l': '0090-9556', 'issn': ['0090-9556', '1521-009X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316283', 'host_organization_name': 'American Society for Pharmacology and Experimental Therapeutics', 'host_organization_lineage': ['https://openalex.org/P4310316283'], 'host_organization_lineage_names': ['American Society for Pharmacology and Experimental Therapeutics'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21451120', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.74}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 19, 'referenced_works': ['https://openalex.org/W152943885', 'https://openalex.org/W1929292775', 'https://openalex.org/W1964906039', 'https://openalex.org/W1969578015', 'https://openalex.org/W2008286529', 'https://openalex.org/W2017218221', 'https://openalex.org/W2024245738', 'https://openalex.org/W2030240071', 'https://openalex.org/W2040233060', 'https://openalex.org/W2069480381', 'https://openalex.org/W2088125097', 'https://openalex.org/W2109530280', 'https://openalex.org/W2113953460', 'https://openalex.org/W2135772015', 'https://openalex.org/W2140661985', 'https://openalex.org/W2146393360', 'https://openalex.org/W2149429360', 'https://openalex.org/W2151943234', 'https://openalex.org/W299766652'], 'related_works': ['https://openalex.org/W4308352595', 'https://openalex.org/W4224031477', 'https://openalex.org/W3212117736', 'https://openalex.org/W3177757153', 'https://openalex.org/W2896979982', 'https://openalex.org/W2139413142', 'https://openalex.org/W2082922601', 'https://openalex.org/W2068005011', 'https://openalex.org/W2034505552', 'https://openalex.org/W2000200648'], 'abstract_inverted_index': {'5-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-pyridin-3-yl]-3-ethyl-2-(2-methoxy-ethyl)-2,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one': [0], '(UK-369,003)': [1], 'is': [2, 12, 20, 200, 228], 'a': [3, 22, 246], 'phosphodiesterase-5': [4], 'inhibitor': [5], 'in': [6, 55, 100, 117, 149, 156, 208], 'clinical': [7], 'development': [8], 'at': [9, 59], 'Pfizer.': [10], 'UK-369,003': [11, 32, 71, 185], 'predominantly': [13], 'metabolized': [14], 'by': [15, 233], 'cytochrome': [16], 'P450': [17], '3A4': [18], 'and': [19, 64, 120, 144, 166, 188, 191, 196], 'also': [21, 73], 'substrate': [23], 'for': [24, 202], 'the': [25, 56, 68, 80, 92, 105, 127, 135, 152, 158, 162, 167, 171, 181, 203, 206, 215, 220, 224, 237], 'efflux': [26], 'transporter': [27], 'P-glycoprotein.': [28], 'The': [29, 139, 177], 'pharmacokinetics': [30, 69, 136, 160], 'of': [31, 39, 44, 61, 70, 79, 104, 126, 137, 141, 154, 161, 170, 184, 205, 214, 223, 241], 'has': [33, 72], 'been': [34, 74], 'profiled': [35], 'after': [36, 76, 186, 212], 'oral': [37, 77, 194], 'administration': [38, 78, 195, 213], '1': [40], 'to': [41, 49, 133, 151, 230, 245], '800': [42], 'mg': [43, 63], 'an': [45], 'immediate': [46, 106, 163, 190, 216], 'release': [47, 85, 94, 107, 164, 173, 193, 217, 226, 235], 'formulation': [48, 165, 227], 'healthy': [50], 'volunteers.': [51], 'Nonlinearity': [52], 'was': [53, 89, 98, 175], 'observed': [54, 211], 'systemic': [57, 182, 209], 'exposure': [58, 88, 183, 210], 'doses': [60], '100': [62], 'greater.': [65], 'In': [66], 'addition,': [67], 'investigated': [75], 'more': [81], 'therapeutically': [82], 'attractive': [83], 'modified': [84, 93, 172, 192, 225], 'formulation.': [86, 108], 'Systemic': [87], 'prolonged': [90], 'with': [91, 102], 'formulation,': [95], 'but': [96], 'bioavailability': [97, 169, 222], 'reduced': [99, 168, 221], 'comparison': [101], 'that': [103, 198], 'Physiologically': [109], 'based': [110, 129], 'pharmacokinetic': [111, 130], 'modeling': [112], 'strategies': [113], 'are': [114], 'commonly': [115], 'used': [116], 'drug': [118], 'discovery': [119], 'development.': [121], 'This': [122], 'work': [123], 'describes': [124], 'application': [125], 'physiologically': [128], 'software': [131], 'GastroPlus': [132], 'understand': [134], 'UK-369,003.': [138], 'impact': [140], 'gut': [142], 'wall': [143], 'hepatically': [145], 'mediated': [146], 'CYP3A4': [147, 199, 249], 'metabolism,': [148], 'addition': [150], 'actions': [153], 'P-glycoprotein,': [155], 'causing': [157], 'nonlinear': [159], 'form,': [174], 'investigated.': [176], 'model': [178], 'accurately': [179], 'described': [180], 'intravenous': [187], 'both': [189], 'suggested': [197], 'responsible': [201], 'majority': [204], 'nonlinearity': [207], 'form.': [218], 'Conversely,': [219], 'believed': [229], 'be': [231], 'caused': [232], 'incomplete': [234, 239], 'from': [236], 'device,': [238], 'absorption': [240], 'released': [242], 'drug,': [243], 'and,': [244], 'lesser': [247], 'extent,': [248], 'metabolism.': [250]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2141289501', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-12-10T02:47:11.472838', 'created_date': '2016-06-24'}